11 Nov 2022 , 03:51 PM
Net profit of Ipca Laboratories declined 42.49% to Rs 143.90 crore in the quarter ended September 2022 as against Rs 250.23 crore during the previous quarter ended September 2021. Sales rose 3.66% to Rs 1600.95 crore in the quarter ended September 2022 as against Rs 1544.43 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 1600.95 | 1544.43 | 4 |
| OPM % | 16.22 | 23.33 | – |
| PBDT | 286.63 | 377.27 | -24 |
| PBT | 222.89 | 320.31 | -30 |
| NP | 143.90 | 250.23 | -42 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
